These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 31825534)
1. Antimicrobial peptide LL-37 and its pro-form, hCAP18, in desquamated epithelial cells of human whole saliva. Aidoukovitch A; Dahl S; Fält F; Nebel D; Svensson D; Tufvesson E; Nilsson BO Eur J Oral Sci; 2020 Feb; 128(1):1-6. PubMed ID: 31825534 [TBL] [Abstract][Full Text] [Related]
2. Exogenous LL-37 but not homogenates of desquamated oral epithelial cells shows activity against Aidoukovitch A; Bankell E; Davies JR; Nilsson BO Acta Odontol Scand; 2021 Aug; 79(6):466-472. PubMed ID: 33687301 [TBL] [Abstract][Full Text] [Related]
3. The host defense peptide LL-37 is detected in human parotid and submandibular/sublingual saliva and expressed in glandular neutrophils. Svensson D; Aidoukovitch A; Anders E; Agerberth B; Andersson F; Ekblad E; Ericson D; Nebel D; Voss U; Nilsson BO Eur J Oral Sci; 2018 Apr; 126(2):93-100. PubMed ID: 29424090 [TBL] [Abstract][Full Text] [Related]
4. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Hase K; Eckmann L; Leopard JD; Varki N; Kagnoff MF Infect Immun; 2002 Feb; 70(2):953-63. PubMed ID: 11796631 [TBL] [Abstract][Full Text] [Related]
5. Antimicrobial protein hCAP18/LL-37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells. Heilborn JD; Nilsson MF; Jimenez CI; Sandstedt B; Borregaard N; Tham E; Sørensen OE; Weber G; Ståhle M Int J Cancer; 2005 May; 114(5):713-9. PubMed ID: 15609314 [TBL] [Abstract][Full Text] [Related]
6. Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori. Hase K; Murakami M; Iimura M; Cole SP; Horibe Y; Ohtake T; Obonyo M; Gallo RL; Eckmann L; Kagnoff MF Gastroenterology; 2003 Dec; 125(6):1613-25. PubMed ID: 14724813 [TBL] [Abstract][Full Text] [Related]
7. The human cathelicidin hCAP18/LL-37: a multifunctional peptide involved in mycobacterial infections. Méndez-Samperio P Peptides; 2010 Sep; 31(9):1791-8. PubMed ID: 20600427 [TBL] [Abstract][Full Text] [Related]
8. Salivary LL-37 secretion in individuals with Down syndrome is normal. Bachrach G; Chaushu G; Zigmond M; Yefenof E; Stabholz A; Shapira J; Merrick J; Chaushu S J Dent Res; 2006 Oct; 85(10):933-6. PubMed ID: 16998135 [TBL] [Abstract][Full Text] [Related]
9. Human cathelicidin antimicrobial protein 18 (hCAP18/LL-37) is increased in foetal membranes and myometrium after spontaneous labour and delivery. Lim R; Barker G; Lappas M J Reprod Immunol; 2015 Feb; 107():31-42. PubMed ID: 25435436 [TBL] [Abstract][Full Text] [Related]
10. Regulation of the human cathelicidin antimicrobial peptide gene by 1α,25-dihydroxyvitamin D3 in primary immune cells. Lowry MB; Guo C; Borregaard N; Gombart AF J Steroid Biochem Mol Biol; 2014 Sep; 143():183-91. PubMed ID: 24565560 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. Zaiou M; Nizet V; Gallo RL J Invest Dermatol; 2003 May; 120(5):810-6. PubMed ID: 12713586 [TBL] [Abstract][Full Text] [Related]
12. Vitamin D triggers hCAP18/LL-37 production: Implications for LL-37-induced human osteoblast cytotoxicity. Aidoukovitch A; Bankell E; Svensson D; Nilsson BO Biochem Biophys Res Commun; 2024 Jun; 712-713():149962. PubMed ID: 38642493 [TBL] [Abstract][Full Text] [Related]
13. Human cathelicidin production by the cervix. Frew L; Makieva S; McKinlay AT; McHugh BJ; Doust A; Norman JE; Davidson DJ; Stock SJ PLoS One; 2014; 9(8):e103434. PubMed ID: 25089904 [TBL] [Abstract][Full Text] [Related]
14. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. Heilborn JD; Nilsson MF; Kratz G; Weber G; Sørensen O; Borregaard N; Ståhle-Bäckdahl M J Invest Dermatol; 2003 Mar; 120(3):379-89. PubMed ID: 12603850 [TBL] [Abstract][Full Text] [Related]
15. Interleukin 13 exposure enhances vitamin D-mediated expression of the human cathelicidin antimicrobial peptide 18/LL-37 in bronchial epithelial cells. Schrumpf JA; van Sterkenburg MA; Verhoosel RM; Zuyderduyn S; Hiemstra PS Infect Immun; 2012 Dec; 80(12):4485-94. PubMed ID: 23045480 [TBL] [Abstract][Full Text] [Related]
16. Overexpressions of hBD-2, hBD-3, and hCAP18/LL-37 in Gingiva of Diabetics with Periodontitis. Yılmaz D; Güncü GN; Könönen E; Barış E; Çağlayan F; Gursoy UK Immunobiology; 2015 Nov; 220(11):1219-26. PubMed ID: 26092093 [TBL] [Abstract][Full Text] [Related]
17. Proinflammatory Cytokines Impair Vitamin D-Induced Host Defense in Cultured Airway Epithelial Cells. Schrumpf JA; Amatngalim GD; Veldkamp JB; Verhoosel RM; Ninaber DK; Ordonez SR; van der Does AM; Haagsman HP; Hiemstra PS Am J Respir Cell Mol Biol; 2017 Jun; 56(6):749-761. PubMed ID: 28231019 [TBL] [Abstract][Full Text] [Related]
18. Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer. Weber G; Chamorro CI; Granath F; Liljegren A; Zreika S; Saidak Z; Sandstedt B; Rotstein S; Mentaverri R; Sánchez F; Pivarcsi A; Ståhle M Breast Cancer Res; 2009; 11(1):R6. PubMed ID: 19183447 [TBL] [Abstract][Full Text] [Related]
19. 25-Hydroxyvitamin D potentializes extracellular cathelicidin release from human PBMC stimulated ex vivo with either bacterial (LPS) or viral (P: IC) mimetics. Aldekwer S; Goncalves-Mendes N; Bingula R; Martinroche G; Lanchais K; Rougé S; Farges MC; Rossary A; Diab-Assaf M; Vasson MP; Talvas J J Physiol Biochem; 2022 May; 78(2):335-342. PubMed ID: 34985728 [TBL] [Abstract][Full Text] [Related]
20. Bacterial phosphorylcholine decreases susceptibility to the antimicrobial peptide LL-37/hCAP18 expressed in the upper respiratory tract. Lysenko ES; Gould J; Bals R; Wilson JM; Weiser JN Infect Immun; 2000 Mar; 68(3):1664-71. PubMed ID: 10678986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]